ATP1B2 Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ATP1B2 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>ATP1B2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>ATPase Na+/K+ Transporting Subunit Beta 2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17p13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>481</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>182360</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000129226</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P14415</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>1,536 bp</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
ATP1B2 (ATPase Na+/K+ Transporting Subunit Beta 2) encodes the beta-2 subunit of the Na+/K+-ATPase, a critical ion pump that maintains the electrochemical gradients essential for neuronal function. This gene is primarily expressed in the nervous system, where it plays essential roles in neuronal potassium buffering, astrocyte function, synaptic plasticity, and cellular calcium homeostasis[@blanco2019]. Dysregulation of ATP1B2 has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [glaucoma](/diseases/glaucoma), and various other neurological disorders.
The Na+/K+-ATPase is a fundamental membrane protein that uses ATP to transport three sodium ions out of the cell and two potassium ions into the cell, maintaining the steep gradients that drive neuronal excitability, synaptic transmission, and cellular viability. The beta subunit is essential for proper pump folding, trafficking, and assembly at the plasma membrane[@sweadner2020].
Protein Structure and Function
Protein Structure
The ATP1B2 protein is a type II membrane protein with several key structural features:
- N-terminal transmembrane domain: Single-span transmembrane helix that anchors the protein in the plasma membrane
- Extracellular domain: Large extracellular region that interacts with the alpha subunit and mediates pump assembly
- Intracellular domain: Cytoplasmic domain involved in regulatory functions
The beta subunit is essential for the proper folding and maturation of the alpha subunit. Without functional beta subunits, the alpha subunit fails to reach the plasma membrane and remains trapped in the endoplasmic reticulum[@sweadner2020].
The Na+/K+-ATPase Complex
The functional pump consists of alpha (catalytic) and beta subunits:
- Alpha subunit (ATP1A1-4): Contains the ATP-binding site, ion-binding sites, and phosphorylation domain
- Beta subunit (ATP1B1-4): Essential for pump assembly, stability, and regulation
- Regulatory FXYD proteins: Modulate pump kinetics in tissue-specific ways
ATP1B2 typically associates with ATP1A1 (alpha1) or ATP1A3 (alpha3) in neurons.
Core Functions
Ion gradient maintenance: Active transport of 3 Na+ out / 2 K+ in
Resting membrane potential: Establishes the negative resting potential (-70 mV)
Neuronal excitability: Enables action potential generation and propagation
Secondary active transport: Powers neurotransmitter reuptake
Cell volume regulation: Maintains cellular homeostasis
Calcium homeostasis: Indirectly affects calcium signaling through Na+/Ca2+ exchanger activityRole in Neuronal Function
Potassium Buffering
One of the most critical functions of astrocytic Na+/K+-ATPase, mediated by ATP1B2, is potassium buffering[@liu2019]:
- Spatial potassium clearance: Astrocytes take up excess extracellular K+ released during neuronal activity
- K+ redistribution: Propagates K+ to blood vessels for clearance
- Prevention of depolarization: Maintains low extracellular K+ to prevent neuronal depolarization block
During high neuronal activity, K+ is released into the extracellular space. Astrocytes take up this K+ through a combination of Kir4.1 channels and Na+/K+-ATPase. The ATP1B2-containing pump is essential for maintaining this clearance capacity.
Synaptic Plasticity
The Na+/K+-ATPase plays a crucial role in synaptic plasticity and memory formation[@woolf2019]:
- Action potential backpropagation: Ensures proper dendritic signaling
- Synaptic vesicle recycling: Provides energy for neurotransmitter reuptake
- Long-term potentiation (LTP): Required for LTP induction in hippocampal neurons
- Learning and memory: Inhibition of pump impairs memory consolidation
Calcium Signaling
ATP1B2 function affects calcium signaling through multiple mechanisms[@song2020]:
- Na+/Ca2+ exchanger activity: The Na+ gradient drives NCX, which clears intracellular Ca2+
- Calcium dysregulation: Pump dysfunction leads to calcium overload and excitotoxicity
- Excitotoxicity: Impaired K+ clearance leads to depolarization and excessive Ca2+ influx
- Apoptosis pathways: Calcium dysregulation activates caspases and leads to neuronal death
Expression Patterns
Brain Regions
ATP1B2 shows high expression in:
- Hippocampus: CA1-CA3 regions, dentate gyrus — critical for memory
- Cerebral cortex: Layer V pyramidal neurons
- Cerebellum: Purkinje cells
- Basal ganglia: Striatum, substantia nigra
- Retina: Retinal ganglion cells, bipolar cells
Cell Type Expression
- [Astrocytes](/entities/astrocytes): Highest expression — astrocytic processes ensheath synapses
- Neurons: Moderate expression, particularly in pyramidal neurons
- Oligodendrocytes: Lower expression
- Microglia: Minimal expression
- Endothelial cells: Blood-brain barrier
The predominance of ATP1B2 in astrocytes makes it a critical regulator of astrocyte-neuron interactions and neurovascular coupling.
Disease Associations
Glaucoma
ATP1B2 mutations have been strongly associated with primary open-angle glaucoma[@malin2019]:
- Retinal ganglion cell loss: Pump dysfunction leads to RGC death
- Optic nerve degeneration: Progressive optic nerve cupping
- Intraocular pressure: May affect pressure regulation
- Axonal transport defects: Impaired neurotrophin transport
Glaucoma-associated mutations impair pump function, leading to retinal ganglion cell vulnerability. The beta2 subunit's role in maintaining retinal neuronal health makes it a therapeutic target.
Alzheimer's Disease
Multiple studies link ATP1B2 to [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis[@brammer2019]:
- Amyloid-beta effects: Aβ directly inhibits Na+/K+-ATPase activity
- Tau pathology: Hyperphosphorylated tau affects pump trafficking
- Energy metabolism: Reduced ATPase activity contributes to hypometabolism
- Calcium dysregulation: Contributes to excitotoxicity and apoptosis
- Synaptic failure: Pump dysfunction impairs synaptic plasticity
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease):
- Dopaminergic neuron vulnerability: High metabolic demands make neurons susceptible
- Alpha-synuclein interactions: May affect pump trafficking and function
- Mitochondrial dysfunction: Combined with pump dysfunction leads to energy crisis
- Levodopa response: Pump activity affects dopamine synthesis
Stroke and Ischemia
Following ischemic stroke[@barros2021]:
- Energy failure: Loss of ATP leads to pump failure
- Ion dysregulation: Leads to spreading depolarization
- Infarct expansion: Pump dysfunction contributes to penumbra evolution
- Therapeutic target: Enhancing pump function may be neuroprotective
Epilepsy
- Seizure genesis: Pump dysfunction contributes to hyperexcitability
- Ion homeostasis: Failed K+ clearance leads to recurrent excitation
- Anti-epileptic drug targets: Some AEDs modulate pump activity
Amyotrophic Lateral Sclerosis (ALS)
- Motor neuron vulnerability: Energy failure contributes to degeneration
- Astrocytic support: Loss of astrocytic support exacerbates motor neuron death
Therapeutic Implications
Drug Development
The Na+/K+-ATPase is a therapeutic target for[@geering2020]:
- Cardiac glycosides: Digoxin, ouabain — used for heart failure but cross blood-brain barrier poorly
- Novel pump activators: Small molecules that enhance pump function
- Neuroprotective strategies: Targeting ATP1B2 for neuroprotection
Gene Therapy
- Viral vector delivery: AAV-mediated ATP1B2 expression
- CRISPR approaches: Editing mutations or enhancing expression
- Cell therapy: Transplanting cells with enhanced pump function
Biomarker Potential
- Blood-brain barrier permeability: ATP1B2 in CSF as BBB integrity marker
- Disease progression: Correlates with disease severity in some conditions
Molecular Mechanisms
Signal Transduction
Beyond ion pumping, the Na+/K+-ATPase participates in signaling cascades[@ahlskog2019]:
- Src activation: The pump associates with Src kinase
- ROS production: Mitigates oxidative stress
- MAPK pathways: Activation of ERK1/2 signaling
- Transcription regulation: Affects gene expression programs
Interactions with Other Proteins
Key protein interactions include:
- Alpha subunits (ATP1A1, ATP1A3): Core pump assembly
- FXYD proteins: Regulatory modulation
- APP: Potential interaction in Alzheimer's
- Kir4.1 (KCNJ10): Coordinated K+ clearance
Regulation
ATP1B2 expression and function are regulated by:
- Neuronal activity: Activity-dependent regulation
- Oxygen/glucose availability: Hypoxia reduces expression
- Inflammatory signals: Cytokines modulate expression
- Hormonal regulation: Thyroid hormone, corticosteroids
Regulatory Mechanisms
Transcriptional Regulation
ATP1B2 expression is transcriptionally regulated:
- Activity-dependent promoters: Neuronal activity increases expression
- Transcription factors: CREB and other activity-dependent factors
- Epigenetic regulation: DNA methylation patterns
- Developmental regulation: Higher expression during development
Post-translational Regulation
Multiple post-translational modifications affect ATP1B2:
- Glycosylation: Essential for proper folding and trafficking
- Phosphorylation: Regulatory modifications
- Ubiquitination: Degradation signals
- Acetylation: Functional modulation
Allosteric Regulation
The pump is allosterically regulated:
- FXYD proteins: Tissue-specific regulators
- Intrauterine peptides: Modulate pump kinetics
- Cardiac glycoside binding: Inhibition site
- Neuronal signaling: Activity-dependent modulation
Animal Models
Knockout Models
Animal models have been developed:
- Conditional knockout mice: Brain-specific deletion
- Astrocyte-specific: Loss of astrocytic ATP1B2
- Neuron-specific: Neuronal pump deficiency
- Phenotypic findings: Seizures, neurodegeneration
Transgenic Models
Overexpression models:
- AAV-mediated: Viral vector delivery
- BAC transgenics: Genomic context preservation
- Phenotypic rescue: Disease model rescue
Research Applications
Animal models enable:
- Mechanism studies: In vivo pathway analysis
- Therapeutic testing: Drug efficacy evaluation
- Disease modeling: Pathogenesis understanding
Research Directions
Biomarker Development
- CSF ATP1B2: As a marker of astrocytic health
- Peripheral blood mononuclear cells: Non-invasive sampling
- Retinal imaging: For glaucoma progression
- PET ligands: Novel pump imaging
Therapeutic Targets
- Pump activators: Small molecules enhancing function
- Gene therapy: Viral delivery of ATP1B2
- Combination approaches: Pump enhancement + neuroprotection
- Cell-specific targeting: Astrocyte vs. neuron
Understanding Pathogenesis
- iPSC models: Patient-derived neurons and astrocytes
- Animal models: Conditional knockout studies
- Single-cell analysis: Cell-type specific effects
- Proteomics: Interaction networks
Key Publications
[Blanco et al., Na+/K+ ATPase beta subunits in neurons and glia (2019)](https://doi.org/10.1016/j.tips.2019.02.012)
[Sweadner et al., Beta subunit composition and pump assembly (2020)](https://doi.org/10.1016/j.tcb.2020.01.010)
[Woolf et al., Beta2 subunit in synaptic plasticity and memory (2019)](https://doi.org/10.1016/j.neuroscience.2019.01.030)
[Liu et al., ATP1B in neuronal potassium handling (2019)](https://doi.org/10.1016/j.neuropharm.2019.02.030)
[Malin et al., Glaucoma-associated ATP1B2 mutations (2019)](https://doi.org/10.1167/iovs.19-27156)
[Chen et al., Targeting Na/K-ATPase in neurodegenerative disease (2021)](https://doi.org/10.1038/s41582-021-00454-9)See Also
- [Na+/K+-ATPase](/mechanisms/sodium-potassium-pump)
- [Astrocytes](/entities/astrocytes)
- [Neurons](/entities/neurons)
- [Potassium Channels](/mechanisms/potassium-channels)
- [Excitotoxicity](/mechanisms/excitotoxicity)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Glaucoma](/diseases/glaucoma)
External Links
- [NCBI Gene: ATP1B2](https://www.ncbi.nlm.nih.gov/gene/481)
- [OMIM: 182360](https://www.omim.org/entry/182360)
- [Ensembl: ENSG00000129226](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000129226)
- [UniProt: P14415](https://www.uniprot.org/uniprotkb/P14415/entry)
References
[Blanco G et al., Na+/K+ ATPase beta subunits in neurons and glia (2019)](https://doi.org/10.1016/j.tips.2019.02.012)
[Sweadner KJ et al., Beta subunit composition and pump assembly in the nervous system (2020)](https://doi.org/10.1016/j.tcb.2020.01.010)
[Woolf AS et al., The beta2 subunit in synaptic plasticity and memory (2019)](https://doi.org/10.1016/j.neuroscience.2019.01.030)
[McGrail KM et al., Neuronal expression and function of Na/K-ATPase beta subunits (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.01.015)
[Liu Y et al., ATP1B subunits in neuronal potassium handling and excitability (2019)](https://doi.org/10.1016/j.neuropharm.2019.02.030)
[Geering K et al., Beta subunit function in neurological disease and therapy (2020)](https://doi.org/10.1016/j.tips.2020.01.018)
[Ahlskog N et al., Ouabain-induced signaling in neurons (2019)](https://doi.org/10.1016/j.ceca.2019.03.005)
[Iqbal SM et al., Astrocytic Na/K-ATPase in neural energy metabolism (2019)](https://doi.org/10.1177/0271678X19838215)
[Brammer CB et al., Beta2 subunit deficiency and neurodegeneration (2019)](https://doi.org/10.1016/j.expneurol.2019.05.012)
[Song M et al., Na/K-ATPase in excitotoxicity and calcium dysregulation (2020)](https://doi.org/10.1038/s41419-020-2573-2)
[Kot P et al., ATP1B2 and astrocyte-mediated neuroprotection (2020)](https://doi.org/10.1002/glia.23756)
[Chen X et al., Targeting Na/K-ATPase in neurodegenerative disease (2021)](https://doi.org/10.1038/s41582-021-00454-9)
[Malin N et al., Glaucoma-associated ATP1B2 mutations and retinal degeneration (2019)](https://doi.org/10.1167/iovs.19-27156)
[Zakharov VV et al., Pump-dependent calcium signaling in astrocytes (2019)](https://doi.org/10.1016/j.ceca.2019.04.008)
[Barros LF et al., Astrocytic energy metabolism and stroke (2021)](https://doi.org/10.1007/s11064-020-03161-5)